QBRI Opens Summer Research Program Applications

Exceptional undergraduate students can now apply to QBRI’s intensive training program

Entity: Qatar Biomedical Research Institute

The program builds on previous successes between 2015 and 2019

Undergraduate students are encouraged to apply to the 2022 edition of the Summer Research Program (SRP) at Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University. Looking to build on the success of previous versions held between 2015 and 2019, the program will offer students eight weeks of intensive training in specific fields of biomedical research, from May 8 to June 30.

SRP participants can expect unique opportunities to gain hands-on laboratory research experience under the supervision of distinguished QBRI researchers in a supportive, challenging, and knowledge conducive environment. That includes learning firsthand about biomedical research protocols and techniques related to biomarker development, and other areas such as stem cells, breast cancer, autism, and diabetes. Students can select from a list of available projects under QBRI’s Diabetes Research Center, Translational Cancer and Immunity Center, and Neurological Disorders Research Center.

Commenting on the Summer Research Program, Lina Hassna, Programs and Partnership Senior Manager at QBRI, said: “We are proud to announce the launch of the sixth edition of the SRP. In its previous versions, this successful program has attracted 70 undergraduate students, some joining HBKU graduate programs and pursuing their master’s and PhD degrees under the supervision of QBRI researchers.”

During the program, students will gain access to QBRI’s state-of-the-art research facilities that are on a par with those at top institutions around the world. In addition, the program will enrich participants’ experience outside the laboratory through a series of seminars, workshops, and informal engagement with the scientific community at QBRI and other leading biomedical research institutions.

“QBRI’s Summer Research Program is an exceptional opportunity for students to experience exciting areas of basic and translational scientific research. Since launching the program in 2015, we have seen the lasting impact for young scientists who have been part of the unique training, and the mentorship and lab experience it comes with. Students will leave better prepared to further their interests in health and biomedical research, and eventually make their own contributions to improving lives,” said Dr. Omar El-Agnaf, Executive Director at QBRI.

To be considered for the competitive program, applicants must be enrolled in an undergraduate program in biological or medical related sciences and have a minimum GPA of 3.0. Applications will be evaluated by QBRI’s selection committee based on a student’s academic record and performance, letters of recommendation, and an interview. The intensive nature of the program requires a full-time commitment over the eight weeks.

The deadline to apply for the SRP 2022 is March 20. Interested students should apply online at hbku.edu.qa/en/srp2022 or direct any inquiries to qbri-srp@hbku.edu.qa.

QBRI Opens Summer Research Program Applications

Exceptional undergraduate students can now apply to QBRI’s intensive training program

Share:

Related News

QBRI Opens Summer Research Program Applications

Exceptional undergraduate students can now apply to QBRI’s intensive training program

Share:

Related News

QBRI Insights: Breast Cancer and the Importance of Awareness

HBKU’s QBRI Wraps Up Summer Research Program

QBRI, QCRI and PHCC Launch Test of Prediabetes Screening Tool

QBRI Scientist Elected to Royal Society of Biology

HBKU Scientists Publish Findings on Neurodegenerative Diseases

QBRI Insights: Medical Problems and Comorbid Conditions Associated with Autism

QBRI Insights: Brain Awareness Week and the Body’s Master Command Center

QBRI is Reaping the Rewards of Collaborative Partnerships

QBRI Applies Precision Medicine to Predict and Treat Severe COVID-19

QBRI Insights: COVID-19 Vaccination - To boost or not to boost

QBRI Concludes Internship Program for High School Students

Scripps Research Agreement to Boost Biomarker and Drug Discovery

QBRI Insights: Breaking Misconceptions and Stereotypes about ADHD

Can Gene Signatures Explain Why Some Breast Cancers Are Resistant to Chemotherapy?

QBRI Insights: Extracellular Vesicles as Novel Biomarkers and Therapeutic Targets for Neurological Disorders

FDA-Approved Alzheimer’s Drug Will Help Spur Innovation Toward Personalized Therapies

Alzheimer’s Disease – Warning Signs, Available Treatments and the Guidelines for Prevention

Huge Potential of HBKU’s Qatar Biomedical Research Institute Convinced Dr. Nasser Hussein Zawia to Accept Opportunity as Research Director

QBRI Insights: Advancing Diabetes Research at QBRI

QBRI Insights: The Pursuit of an Effective Anti-Cancer Target

QBRI Insights: Breast Cancer and the Importance of Awareness

HBKU’s QBRI Wraps Up Summer Research Program

QBRI, QCRI and PHCC Launch Test of Prediabetes Screening Tool

QBRI Scientist Elected to Royal Society of Biology

HBKU Scientists Publish Findings on Neurodegenerative Diseases

QBRI Insights: Medical Problems and Comorbid Conditions Associated with Autism

QBRI Insights: Brain Awareness Week and the Body’s Master Command Center

QBRI is Reaping the Rewards of Collaborative Partnerships

QBRI Applies Precision Medicine to Predict and Treat Severe COVID-19

QBRI Insights: COVID-19 Vaccination - To boost or not to boost

QBRI Concludes Internship Program for High School Students

Scripps Research Agreement to Boost Biomarker and Drug Discovery

QBRI Insights: Breaking Misconceptions and Stereotypes about ADHD

Can Gene Signatures Explain Why Some Breast Cancers Are Resistant to Chemotherapy?

QBRI Insights: Extracellular Vesicles as Novel Biomarkers and Therapeutic Targets for Neurological Disorders

FDA-Approved Alzheimer’s Drug Will Help Spur Innovation Toward Personalized Therapies

Alzheimer’s Disease – Warning Signs, Available Treatments and the Guidelines for Prevention

Huge Potential of HBKU’s Qatar Biomedical Research Institute Convinced Dr. Nasser Hussein Zawia to Accept Opportunity as Research Director

QBRI Insights: Advancing Diabetes Research at QBRI

QBRI Insights: The Pursuit of an Effective Anti-Cancer Target

QBRI Insights: Breast Cancer and the Importance of Awareness

HBKU’s QBRI Wraps Up Summer Research Program

QBRI, QCRI and PHCC Launch Test of Prediabetes Screening Tool

QBRI Scientist Elected to Royal Society of Biology

HBKU Scientists Publish Findings on Neurodegenerative Diseases

QBRI Insights: Medical Problems and Comorbid Conditions Associated with Autism

QBRI Insights: Brain Awareness Week and the Body’s Master Command Center

QBRI is Reaping the Rewards of Collaborative Partnerships

QBRI Applies Precision Medicine to Predict and Treat Severe COVID-19

QBRI Insights: COVID-19 Vaccination - To boost or not to boost

QBRI Concludes Internship Program for High School Students

Scripps Research Agreement to Boost Biomarker and Drug Discovery

QBRI Insights: Breaking Misconceptions and Stereotypes about ADHD

Can Gene Signatures Explain Why Some Breast Cancers Are Resistant to Chemotherapy?

QBRI Insights: Extracellular Vesicles as Novel Biomarkers and Therapeutic Targets for Neurological Disorders

FDA-Approved Alzheimer’s Drug Will Help Spur Innovation Toward Personalized Therapies

Alzheimer’s Disease – Warning Signs, Available Treatments and the Guidelines for Prevention

Huge Potential of HBKU’s Qatar Biomedical Research Institute Convinced Dr. Nasser Hussein Zawia to Accept Opportunity as Research Director

QBRI Insights: Advancing Diabetes Research at QBRI

QBRI Insights: The Pursuit of an Effective Anti-Cancer Target

QBRI Insights: Breast Cancer and the Importance of Awareness

HBKU’s QBRI Wraps Up Summer Research Program

QBRI, QCRI and PHCC Launch Test of Prediabetes Screening Tool

QBRI Scientist Elected to Royal Society of Biology

HBKU Scientists Publish Findings on Neurodegenerative Diseases

QBRI Insights: Medical Problems and Comorbid Conditions Associated with Autism

QBRI Insights: Brain Awareness Week and the Body’s Master Command Center

QBRI is Reaping the Rewards of Collaborative Partnerships

QBRI Applies Precision Medicine to Predict and Treat Severe COVID-19

QBRI Insights: COVID-19 Vaccination - To boost or not to boost

QBRI Concludes Internship Program for High School Students

Scripps Research Agreement to Boost Biomarker and Drug Discovery

QBRI Insights: Breaking Misconceptions and Stereotypes about ADHD

Can Gene Signatures Explain Why Some Breast Cancers Are Resistant to Chemotherapy?

QBRI Insights: Extracellular Vesicles as Novel Biomarkers and Therapeutic Targets for Neurological Disorders

FDA-Approved Alzheimer’s Drug Will Help Spur Innovation Toward Personalized Therapies